Weight loss treatments have evolved rapidly in recent years, offering new hope for people seeking effective and convenient options. Eli Lilly’s newly FDA-approved oral tablet, Foundayo (orforglipron), joins this growing field as an alternative to injectable medications like Mounjaro and Wegovy, and in direct competition with Novo Nordisk's current offering of oral semaglutide (Ozempic/Wegovy), which is available in the UK as Rybelsus. Foundayo oral tablet close-up What is Fou

Results of a late-stage trial show that Type 2 diabetes patients using Eli Lilly’s highly anticipated next-generation weight-loss drug Retatrutide experienced a significant reduction in blood-sugar levels and weight loss...

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with Semaglutide, the well-known active ingredient within Ozempic, Rybelsus and Wegovy.

Many people experience significant weight loss using GLP-1 medications like Wegovy and Mounjaro. These drugs help control appetite and improve metabolism, making it easier to focus on losing weight. But what happens when the medication stops? Without a plan, the risk of regaining weight is high. This post explores how to maintain weight loss after stopping GLP-1 medications by focusing on healthy eating, nutrition, exercise, and mindset. Building sustainable habits is key to

Weight-loss drugs could treat addiction to alcohol, cigarettes and drugs, research shows. Experts believe the way the medicines work on the brain’s reward pathway reduces cravings for many different substances.

Maintaining weight loss can be more challenging than losing the weight itself. Many people find that after reaching their target weight, old habits creep back in, and the scale starts to climb again. The key to lasting weight management lies in a balanced approach that includes changes in diet, gradual increases in exercise, and, when applicable, thoughtful adjustments to medications like Mounjaro or Wegovy.

Losing weight is a journey filled with challenges and victories. One of the most powerful tools to stay on course is progress tracking. When you can see how far you've come, it fuels motivation and helps you understand what works and what needs adjustment. This clarity supports healthier habits that last beyond quick fixes or fad diets.

Weight loss is often seen as a quick fix, a goal to achieve through the latest fad diet or a new supplement. Yet, many people find themselves caught in a cycle of failed diets and temporary results. The truth is that lasting weight loss depends far more on changing your habits and mindset than on any short-term plan. Sustainable lifestyle changes build a foundation for long-term weight management and overall well-being. This post explores how shifting your mindset and devel

You may feel hesitant when it comes to travelling with this treatment but we have broken down the best ways to stay on track with your treatment when you go away. You can enjoy your time away and take your medication worry-free.

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

The US Food and Drug Administration (FDA) has approved a tablet version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. Although Oral Semaglutide is already on the market in the UK as the brand Rybelsus, this is currently licensed for Type 2 Diabetes. However, Rybelsus can be prescribed off-label for weight loss within the UK by a qualified healthcare professional, which is helpful for those who do not like injections or have needle phobia. Thi

Researchers say daily calorie intake may be up to 10 times more influential than physical activity in weight gain.

Compared to Mounjaro, which also promotes weight loss, Semaglutide has a similar impact on ALT reduction. Both drugs improve liver enzymes by reducing fat and inflammation, but Semaglutide’s longer track record provides more data on liver outcomes.

There are no strict dietary restrictions with Mounjaro, but eating balanced, nutrient-rich meals helps the medication work most effectively. Many people find smaller portions and lighter meals are easier to tolerate, especially early on. Limiting high-fat, spicy, or overly rich foods can also reduce nausea and improve comfort while your body adjusts. Why diet still matters with Mounjaro NICE (TA1026, 2025) and NHS guidance both stress that Mounjaro should be used alongside a

At the moment, there is no generic version of Mounjaro available. The medication is still under patent protection, meaning only Eli Lilly can produce tirzepatide until that period ends. Generic versions may become available in future years, once regulatory timelines and patent conditions allow. Understanding what “generic” means A generic medicine is an equivalent version of a branded drug that becomes available once patent and exclusivity rights expire. It must contain the s

A major new review has pitted the big three weight management products against each other – it looks at comparing the weight lost with each product and how long users were able to maintain their weight loss. There are several weight loss treatments now available in the UK via the NHS and private clinics Scientists compar ed tirzepatide – the active ingredient of Mounjaro – to semaglutide, which is in Wegovy and Ozempic, and liraglutide, that’s in Saxenda. he reviews – publish

Mounjaro was developed by the pharmaceutical company Eli Lilly and first approved for medical use in 2022. It’s based on years of research into dual hormone therapies that target both GIP and GLP-1 pathways. Its effectiveness has since been demonstrated in large international trials, helping establish it as a new generation of treatment for type 2 diabetes and weight management. How Mounjaro began The story of Mounjaro started in the early 2010s, when researchers explored way

Mounjaro doesn’t “speed up” metabolism in the traditional sense, but it improves how your body processes glucose and stores energy. By enhancing insulin sensitivity and reducing appetite, it helps the body use energy more efficiently. Over time, this balance can lead to gradual fat loss and better overall metabolic health. How Mounjaro supports metabolic function Metabolism is the body’s process of converting food into energy. NICE (TA1026, 2025) explains that tirzepatide — t

Mounjaro is not usually prescribed alongside other weight-loss injections or tablets, as combining treatments that affect similar hormone pathways could increase side effects or complications. Doctors generally recommend using it as a single therapy so its effects can be properly monitored. If you’re already on another weight management medication, your clinician will advise whether it’s best to pause or switch before starting Mounjaro. Why Mounjaro is used alone NICE (TA1026

Mounjaro works by activating areas in the brain that sense fullness and regulate food intake. This helps reduce appetite while enhancing satiety, meaning you feel content with less food. Over time, it can help reshape eating patterns by supporting a more natural balance between hunger and satisfaction. The science behind hunger control Appetite control depends on communication between the gut and the brain. After eating, the body releases two hormones — GLP-1 (glucagon-like p